NYSE: EVH |
| Healthcare / Healthcare Providers & Services / USA |
30.94 | -0.8700 | -2.73% | Vol 592.36K | 1Y Perf 53.15% |
Jun 28th, 2022 16:00 DELAYED |
BID | 28.41 | ASK | 32.62 | ||
Open | 32.08 | Previous Close | 31.81 | ||
Pre-Market | - | After-Market | 30.94 | ||
- - | - -% |
Target Price | 42.00 | Analyst Rating | Strong Buy 1.00 | |
Potential % | 35.75 | Finscreener Ranking | ★★★ 50.36 | |
Insiders Trans % 3/6/12 mo. | -/-100/-100 | Value Ranking | ★★ 46.49 | |
Insiders Value % 3/6/12 mo. | -/-100/-100 | Growth Ranking | ★+ 40.42 | |
Insiders Shares Cnt. % 3/6/12 mo. | -/-100/-100 | Income Ranking | — - | |
Price Range Ratio 52W % | 74.49 | Earnings Rating | Strong Buy | |
Market Cap | 2.83B | Earnings Date | 3rd Aug 2022 | |
Alpha | -0.00 | Standard Deviation | 0.19 | |
Beta | 2.07 |
Today's Price Range 30.6532.44 | 52W Range 20.2534.60 | 5 Year PE Ratio Range -12.80-4.60 |
Summary:
Buy
Technical Indicators: | Buy |
Moving Averages: | Strong Buy |
Performance | |||
---|---|---|---|
1 Week | 7.61% | ||
1 Month | 8.23% | ||
3 Months | 2.02% | ||
6 Months | 16.91% | ||
1 Year | 53.15% | ||
3 Years | 300.13% | ||
5 Years | 25.24% | ||
10 Years | - |
Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
ROE (5Y Avg) | -15.13 | |||
ROE last 12 Months | -5.55 | |||
ROA (5Y Avg) | -9.92 | |||
ROA last 12 Months | -2.58 | |||
ROC (5Y Avg) | -11.88 | |||
ROC last 12 Months | -2.20 | |||
Return on invested Capital Q | -0.40 | |||
Return on invested Capital Y | -0.11 | |||
Assets Turnover | 0.80 | |||
Receivables Turnover | 6.70 |
Valuation | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
-81.00 | ||||
4.74 | ||||
2.94 | ||||
93.60 | ||||
-70.90 | ||||
0.34 | ||||
-33.16 | ||||
6.67 | ||||
3.03B | ||||
Forward PE | 108.96 | |||
PEG | - |
Financial Strength | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
1.00 | ||||
1.20 | ||||
0.36 | ||||
0.57 | ||||
-0.10 | ||||
Leverage Ratio | 2.10 |
Profitability | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
27.30 | ||||
-0.20 | ||||
5.90 | ||||
-21.20 | ||||
-3.34 |
Revenue | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
989.94M | ||||
10.81 | ||||
9.10 | ||||
23.80 |
Dividends | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
- | ||||
- | ||||
- | ||||
- | ||||
Payout ratio | - |
Earnings History | Estimate | Reported | Surprise % |
---|---|---|---|
Q01 2022 | -0.08 | 0.06 | 175.00 |
Q04 2021 | -0.06 | 0.02 | 133.33 |
Q03 2021 | -0.08 | -0.08 | 0.00 |
Q02 2021 | -0.11 | -0.06 | 45.45 |
Q01 2021 | -0.10 | -0.06 | 40.00 |
Q04 2020 | -0.10 | -0.06 | 40.00 |
Q03 2020 | -0.13 | -0.07 | 46.15 |
Q02 2020 | -0.17 | -0.07 | 58.82 |
Earnings Per End | Estimate | Revision % | Trend |
---|---|---|---|
6/2022 QR | -0.04 | 50.00 | Positive |
9/2022 QR | -0.03 | 57.14 | Positive |
12/2022 FY | -0.03 | 86.36 | Positive |
12/2023 FY | 0.29 | 262.50 | Positive |
Next Report Date | 3rd Aug 2022 |
Estimated EPS Next Report | -0.04 |
Estimates Count | 4 |
EPS Growth Next 5 Years % | - |
Volume Overview | |
---|---|
Volume | 592.36K |
Shares Outstanding | 91.59K |
Shares Float | 83.93M |
Trades Count | 7.68K |
Dollar Volume | 18.49M |
Avg. Volume | 817.43K |
Avg. Weekly Volume | 964.92K |
Avg. Monthly Volume | 776.89K |
Avg. Quarterly Volume | 710.48K |
Evolent Health Inc Class A (NYSE: EVH) stock closed at 31.81 per share at the end of the most recent trading day (a 0.66% change compared to the prior day closing price) with a volume of 551.62K shares and market capitalization of 2.83B. Is a component of indices and it is traded on NYSE exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 2900 people. Evolent Health Inc Class A CEO is Seth Blackley.
The one-year performance of Evolent Health Inc Class A stock is 53.15%, while year-to-date (YTD) performance is 14.96%. EVH stock has a five-year performance of 25.24%. Its 52-week range is between 20.25 and 34.6, which gives EVH stock a 52-week price range ratio of 74.49%
Evolent Health Inc Class A currently has a PE ratio of -81.00, a price-to-book (PB) ratio of 4.74, a price-to-sale (PS) ratio of 2.94, a price to cashflow ratio of 93.60, a PEG ratio of 2.32, a ROA of -2.58%, a ROC of -2.20% and a ROE of -5.55%. The company’s profit margin is -3.34%, its EBITDA margin is 5.90%, and its revenue ttm is $989.94 Million , which makes it $10.81 revenue per share.
Of the last four earnings reports from Evolent Health Inc Class A, there were 3 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $-0.04 for the next earnings report. Evolent Health Inc Class A’s next earnings report date is 03rd Aug 2022.
The consensus rating of Wall Street analysts for Evolent Health Inc Class A is Strong Buy (1), with a target price of $42, which is +35.75% compared to the current price. The earnings rating for Evolent Health Inc Class A stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Evolent Health Inc Class A has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Evolent Health Inc Class A has a Buy technical analysis rating based on Technical Indicators (ADX : 12.78, ATR14 : 1.47, CCI20 : 144.65, Chaikin Money Flow : 0.20, MACD : 0.47, Money Flow Index : 74.27, ROC : 7.03, RSI : 63.87, STOCH (14,3) : 89.76, STOCH RSI : 1.00, UO : 60.15, Williams %R : -10.24), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Evolent Health Inc Class A in the last 12-months were: Frank J. Williams (Option Excercise at a value of $748 800), Frank J. Williams (Sold 262 370 shares of value $6 335 274 ), Jonathan D. Weinberg (Sold 0 shares of value $-205 175 ), Jonathan D. Weinberg (Sold 53 431 shares of value $1 401 559 ), Seth Blackley (Sold 0 shares of value $-576 000 ), Seth Blackley (Sold 150 000 shares of value $4 479 000 ), Steve Tutewohl (Sold 0 shares of value $-919 897 ), Steve Tutewohl (Sold 69 713 shares of value $1 615 225 )
Analyst Ratings | Current | 1 M ago | 3 M ago |
---|---|---|---|
Strong Buy | |||
Moderate Buy | |||
Hold | |||
Moderate Sell | |||
Strong Sell | |||
Summary Rating | Strong Buy | Strong Buy | Strong Buy |
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. The company's reportable segments are Service segment which includes value-based care services, specialty care management services and comprehensive health plan administration services. and True Health segment consists of a commercial health plan it operates in New Mexico that focuses on small and large businesses. It generates a majority of its revenue from the Service segment.
CEO: Seth Blackley
Telephone: +1 571 389-6000
Address: 800 N. Glebe Road, Arlington 22203, VA, US
Number of employees: 2 900
Copyright © 2016-2022 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
All rights reserved. Financial Market Data powered by Quotemedia.com. All rights reserved. View the Terms of Use. CBOE EDGX Top real-time data for Premium users, NYSE/NYSE MKT (AMEX) data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless otherwise indicated. Technology and data provided by TeleTrader. Conditions of Use. The regulations of the respective stock are to be observed. Copyright © 2022. All market data is provided by Quotemedia.com. Futures: at least a 10 minute delay. Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. To see all exchange delays and terms of use, please see disclaimer. The Cryptocurrency Market real-time data provided by Cryptocompare.com
eToro USA LLC does not offer CFDs and makes no representation and assumes no liability as to the accuracy or completeness of the content of this publication, which has been prepared by our partner utilizing publicly available non-entity specific information about eToro. Your capital is at risk.
Don´t have an account? Register
Looks like you are using AdBlock.
The revenue earned from advertising enables us to provide the quality content you are trying to reach on this website. In order to view this page, please disable AdBlock or purchase Premium.
Sign in if you already have Premium account.
This could take some time, please wait.